You just read:

FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth

News provided by

K-V Pharmaceutical Company

Feb 04, 2011, 08:30 ET